A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemiaChatchada Karanes, Frederick R. Appelbaum, Kenneth J. Kopecky et al.|Leukemia Research|1999Cited by 88
Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibitionSerhan Alkan, Keith F. Izban, Gladell P. Paner et al.|American Journal of Hematology|2005Cited by 35
Real World Outcomes of Sars-Cov-2 Thrombosis Rates across Three University Health Systems in the Chicago Metropolitan AreaStephanie Berg, Santosh L. Saraf, Seohyun Kim et al.|Blood|2020Cited by 1